Sphingolipid metabolism in cancer signalling and therapy

B Ogretmen - Nature Reviews Cancer, 2018 - nature.com
Sphingolipids, including the two central bioactive lipids ceramide and sphingosine-1-
phosphate (S1P), have opposing roles in regulating cancer cell death and survival …

Roles of sphingosine-1-phosphate signaling in cancer

P Wang, Y Yuan, W Lin, H Zhong, K Xu, X Qi - Cancer cell international, 2019 - Springer
The potent pleiotropic lipid mediator sphingosine-1-phosphate (S1P) participates in
numerous cellular processes, including angiogenesis and cell survival, proliferation, and …

S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma

Y Shen, S Zhao, S Wang, X Pan, Y Zhang, J Xu… - …, 2019 - thelancet.com
Background Osteosarcoma (OS) is a malignant tumor mainly occurring in young people.
Due to the limited effective therapeutic strategies, OS patients cannot achieve further …

Sphingosine-1-phosphate: its pharmacological regulation and the treatment of multiple sclerosis: a review article

S Cohan, E Lucassen, K Smoot, J Brink, C Chen - Biomedicines, 2020 - mdpi.com
Sphingosine-1-phosphate (S1P), via its G-protein-coupled receptors, is a signaling molecule
with important regulatory properties on numerous, widely varied cell types. Five S1P …

Targeting sphingolipid metabolism as a therapeutic strategy in cancer treatment

AH Janneh, B Ogretmen - Cancers, 2022 - mdpi.com
Simple Summary Sphingolipids, which are important cell membrane components, have
critical roles in regulating cancer cell signaling to control pro-tumoral or antitumoral …

Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages via TWIK2-mediated potassium efflux

Y Wang, C Wang, Q He, G Chen, J Yu, J Cang… - Frontiers in …, 2023 - frontiersin.org
Background Inhibition of sphingosine kinase 1 (SphK1), which catalyzes bioactive lipid
sphingosine-1–phosphate (S1P), attenuates NLRP3 inflammasome activation. S1P exerts …

Lipid phosphate phosphatases and cancer

X Tang, DN Brindley - Biomolecules, 2020 - mdpi.com
Lipid phosphate phosphatases (LPPs) are a group of three enzymes (LPP1–3) that belong
to a phospholipid phosphatase (PLPP) family. The LPPs dephosphorylate a wide spectrum …

Sphingolipid metabolism in glioblastoma and metastatic brain tumors: a review of sphingomyelinases and sphingosine-1-phosphate

CC Hawkins, T Ali, S Ramanadham, AB Hjelmeland - Biomolecules, 2020 - mdpi.com
Glioblastoma (GBM) is a primary malignant brain tumor with a dismal prognosis, partially
due to our inability to completely remove and kill all GBM cells. Rapid tumor recurrence …

Targeting SPHK1/PBX1 axis induced cell cycle arrest in non-small cell lung cancer

Z Lin, Y Li, X Han, Z Fu, Z Tian, C Li - International Journal of Molecular …, 2022 - mdpi.com
Non-small cell lung cancer (NSCLC) accounts for 85~ 90% of lung cancer cases, with a poor
prognosis and a low 5-year survival rate. Sphingosine kinase-1 (SPHK1), a key enzyme in …

The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases

A Goto, M Tanaka, M Yoshida, M Umakoshi, H Nanjo… - PLoS …, 2017 - journals.plos.org
Purpose miR-451 is a tumor suppressive microRNA with several target genes, including
Macrophage migration inhibitory factor (MIF). As little is known about the expression and …